Human Papillomavirus testing for the management of low-grade cervical abnormalities in the UK-Influence of age and testing strategy

Journal of Clinical Virology

Volumn 38, Issue 1, 2007, Pages 14-18

  Cuschieri, K S ^a   Graham, C ^b   Moore, C ^a   Cubie, H A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Age; HPV testing; Low grade cervical cytology

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS DETECTION; WART VIRUS;

ADULT; CERVIX UTERI; CROSS-SECTIONAL STUDIES; CYTODIAGNOSIS; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DISEASES;

EID: 33845302604     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.10.007     Document Type: Article

References (12)

1. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infection. J Clin Virol 32S (2005) S16-S24
2. Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M.J., Moore C., et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57 (2004) 68-72
3. Eltoum I.A., Chieng D.C., Roberson J., and Partridge E.E. Reflex human papillomavirus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer 105 (2005) 194-198
4. Kim J.J., Wright T.C., and Goldie S.J. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France and Italy. J Natl Cancer Inst 97 (2005) 888-895
5. Kinney W.K., Maon M.M., Hurley L.B., and Ransley J.E. Where's the high-grade neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 91 (1998) 973-976
6. Kulasingam S.L., Kim J.J., Lawrence W.F., Mandelblatt J.S., Myers E.R., Schiffman M., et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study. J Natl Cancer Inst 18 (2006) 92-100
7. Legood R.L., Gray A., Wolstenholme J., and Moss S. Lifetime effects, costs and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: modelling study. BMJ 14 (2006) 79-85 10.1136/bmj.38698.458866.7C
8. Liquid Based Cytology/Human Papillomavirus Cervical Pilot Studies Group. Effect of testing for human papillomavirus as triage during screening for cervical cancer: observational before and after study. BMJ 332 (2006) 83-85 10.1136/bmj.38701.440961.7C
9. ® Human Papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol 99 (2005) 160-168
10. Rana D.N., Marshall J., Desai M., Kitchener H.C., Perera D.M., El Terafi H., et al. Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears. Cytopathology 15 (2004) 263-270
11. ® Human papillomavirus (HPV) test for the detection of high-risk HPV genotypes in DNA extracts from liquid-based cytology samples collected from women whose cytology was graded borderline. 21st international papillomavirus conference. Mexico City, February 21-26 (2004) [abstract]
12. Schiffman M., and Castle P.E. When to test women for human papillomavirus. BMJ 14 332 (2006) 61-62